0QZ5 Stock Chart & Stats
$50.78
-$1.28(-2.51%)
At close: 4:00 PM EDT
$50.78
-$1.28(-2.51%)
Day’s Range― - ―
52-Week Range$37.09 - $87.52
Previous CloseN/A
Volume300.00
Average Volume (3M)6.84K
Market Cap
$27.97B
Enterprise Value$19.09K
Total Cash (Recent Filing)$1.05B
Total Debt (Recent Filing)$2.09B
Price to Earnings (P/E)13.7
Beta0.81
Next Earnings
Nov 04, 2026EPS Estimate
1.47Next Dividend Ex-DateN/A
Dividend Yield2.04%
Share Statistics
EPS (TTM)4.66
Shares Outstanding450,444,200
10 Day Avg. Volume4,979
30 Day Avg. Volume6,840
Financial Highlights & Ratios
PEG Ratio20.57
Price to Book (P/B)2.66
Price to Sales (P/S)1.89
P/FCF Ratio15.38
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$61.67Price Target Upside21.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering21
EPS Forecast (FY)5.75
Revenue Forecast (FY)$22.19B
Bulls Say, Bears Say
Bulls Say
Strong Balance Sheet And Cash GenerationLow leverage gives Cognizant financial flexibility through demand cycles, while strong free cash flow supports investment, acquisitions, dividends, and repurchases. High cash conversion also indicates that reported earnings are supported by durable operating cash generation.
Improving Demand And Bookings MomentumDouble-digit financial-services growth and healthy bookings indicate improving enterprise technology demand and future revenue coverage. Large deals and expansion bookings can deepen client relationships and create a durable base for cross-selling and managed-services growth.
AI And Platform-led DifferentiationAI delivery capabilities, ecosystem partnerships, and healthcare platform assets can shift Cognizant toward higher-value, repeatable offerings. TriZetto’s scale and superior margins provide evidence that platform-led solutions may improve mix and revenue durability.
Bears Say
Long-term Margin CompressionMargin deterioration versus prior years suggests continuing exposure to pricing pressure, wage inflation, or a less favorable service mix. Even with recent expansion, sustained compression could limit earnings growth and reduce the benefit of recovering revenue demand.
Cautious Enterprise SpendingOngoing scrutiny of discretionary technology budgets can lengthen sales cycles, delay transformation programs, and constrain consulting volumes across several industries. This creates a structural risk that bookings convert to revenue more slowly than expected.
Working-capital And Financing PressureHigher receivables days can delay cash conversion and increase the funding required to support growth. Revolver-financed acquisitions and repurchases add interest costs, reducing financial flexibility if customer collections or operating conditions weaken.
Cognizant News
0QZ5 FAQ
What was Cognizant Technology Solutions’s price range in the past 12 months?
Cognizant Technology Solutions lowest share price was $37.09 and its highest was $87.52 in the past 12 months.
What is Cognizant Technology Solutions’s market cap?
Cognizant Technology Solutions’s market cap is $27.97B.
When is Cognizant Technology Solutions’s upcoming earnings report date?
Cognizant Technology Solutions’s upcoming earnings report date is Nov 04, 2026 which is in 67 days.
How were Cognizant Technology Solutions’s earnings last quarter?
Cognizant Technology Solutions released its earnings results on Jul 29, 2026. The company reported $1.37 earnings per share for the quarter, missing the consensus estimate of $1.377 by -$0.007.
Is Cognizant Technology Solutions overvalued?
According to Wall Street analysts Cognizant Technology Solutions’s price is currently Undervalued.
Does Cognizant Technology Solutions pay dividends?
Cognizant Technology Solutions pays a Quarterly dividend of $0.33 which represents an annual dividend yield of 2.04%. See more information on Cognizant Technology Solutions dividends here
What is Cognizant Technology Solutions’s EPS estimate?
Cognizant Technology Solutions’s EPS estimate is 1.47.
How many shares outstanding does Cognizant Technology Solutions have?
Cognizant Technology Solutions has 450,444,200 shares outstanding.
What happened to Cognizant Technology Solutions’s price movement after its last earnings report?
Cognizant Technology Solutions reported an EPS of $1.37 in its last earnings report, missing expectations of $1.377. Following the earnings report the stock price went up 11.471%.
Which hedge fund is a major shareholder of Cognizant Technology Solutions?
Currently, no hedge funds are holding shares in GB:0QZ5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cognizant Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$61.67 (21.44% Upside)
$61.67 (21.44% Upside)
Blogger Sentiment
Bullish
GB:0QZ5 Sentiment 91%
Sector Average 59%
Sector Average 59%
Insider Transactions
Bought Shares
Worth $209.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.51%
12-Months-Change
Fundamentals
Return on Equity
2.04%
Trailing 12-Months
Asset Growth
3.28%
Trailing 12-Months
Company Description
Cognizant Technology Solutions
Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New Jersey.
0QZ5 Company Deck
0QZ5 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a predominantly positive operational and strategic picture: revenue growth, margin expansion, strong bookings and large‑deal momentum (particularly in financial services), accelerated AI adoption and platform initiatives, meaningful share repurchases, and healthy free cash flow. Notable near‑term headwinds include Project LEAP costs, India labor reforms run‑rate impacts, higher interest expense from revolver use for acquisitions and buybacks, higher DSO, some industry pockets of muted demand, and observable AI execution/ROI challenges across a portion of the Global 2000. On balance, the positive growth, margin recovery, and AI‑led strategy and execution appear to outweigh the lowlights.View all GB:0QZ5 earnings summaries0QZ5 Revenue Breakdown
30.06% Health Sciences
29.15% Financial Services
24.23% Products and Resources
16.56% Communications, Media and Technology
0QZ5 Stock 12 Month Forecast
Average Price Target
$61.67
▲(21.44% Upside)